PT - JOURNAL ARTICLE AU - Yu, Dalang AU - Yang, Xiao AU - Tang, Bixia AU - Pan, Yi-Hsuan AU - Yang, Jianing AU - Duan, Guangya AU - Zhu, Junwei AU - Hao, Zi-Qian AU - Mu, Hailong AU - Dai, Long AU - Hu, Wangjie AU - Zhang, Mochen AU - Cui, Ying AU - Jin, Tong AU - Li, Cui-Ping AU - Ma, Lina AU - , AU - Su, Xiao AU - Zhang, Guoqing AU - Zhao, Wenming AU - Li, Haipeng TI - Coronavirus GenBrowser for monitoring the transmission and evolution of SARS-CoV-2 AID - 10.1101/2020.12.23.20248612 DP - 2021 Jan 01 TA - medRxiv PG - 2020.12.23.20248612 4099 - http://medrxiv.org/content/early/2021/10/19/2020.12.23.20248612.short 4100 - http://medrxiv.org/content/early/2021/10/19/2020.12.23.20248612.full AB - Genomic epidemiology is important to study the COVID-19 pandemic and more than two million SARS-CoV-2 genomic sequences were deposited into public databases. However, the exponential increase of sequences invokes unprecedented bioinformatic challenges. Here, we present the Coronavirus GenBrowser (CGB) based on a highly efficient analysis framework and a movie maker strategy. In total, 1,002,739 high quality genomic sequences with the transmission-related metadata were analyzed and visualized. The size of the core data file is only 12.20 MB, efficient for clean data sharing. Quick visualization modules and rich interactive operations are provided to explore the annotated SARS-CoV-2 evolutionary tree. CGB binary nomenclature is proposed to name each internal lineage. The pre-analyzed data can be filtered out according to the user-defined criteria to explore the transmission of SARS-CoV-2. Different evolutionary analyses can also be easily performed, such as the detection of accelerated evolution and on-going positive selection. Moreover, the 75 genomic spots conserved in SARS-CoV-2 but non-conserved in other coronaviruses were identified, which may indicate the functional elements specifically important for SARS-CoV-2. The CGB not only enables users who have no programming skills to analyze millions of genomic sequences, but also offers a panoramic vision of the transmission and evolution of SARS-CoV-2.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by a grant from the National Key Research and Development Project (No. 2020YFC0847000).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll timely-updated data are freely available at https://bigd.big.ac.cn/ncov/apis/. The desktop standalone version provides the full function of CGB and has a plug-in module for the eGPS software (http://www.egps-software.net/egpscloud/eGPS_Desktop.html).